Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 1
2016 1
2019 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.
Gibson CM, Duffy D, Bahit MC, Chi G, White H, Korjian S, Alexander JH, Lincoff AM, Heise M, Kingwell BA, Nicolau JC, Lopes RD, Cornel JH, Lewis BS, Vinereanu D, Goodman SG, Bode C, Steg PG, Libby P, Sacks FM, Bainey KR, Ridker PM, Mahaffey KW, Aylward P, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators. Gibson CM, et al. Eur Heart J. 2024 Dec 16;45(47):5023-5038. doi: 10.1093/eurheartj/ehae614. Eur Heart J. 2024. PMID: 39221651 Clinical Trial.
Comments on the 2014 ESC Guidelines on the diagnosis and management of hypertrophic cardiomyopathy. A critical view from the perspective of Spanish cardiology.
SEC Working Group for the 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy; Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Hypertrophic Cardiomyopathy; SEC Clinical Practice Guidelines Committee. SEC Working Group for the 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy, et al. Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):4-9. doi: 10.1016/j.rec.2014.10.011. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25553935 No abstract available.
Prehospital ticagrelor in ST-segment elevation myocardial infarction.
Montalescot G, van 't Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Stibbe O, Ecollan P, Heutz WM, Swahn E, Collet JP, Willems FF, Baradat C, Licour M, Tsatsaris A, Vicaut E, Hamm CW; ATLANTIC Investigators. Montalescot G, et al. N Engl J Med. 2014 Sep 11;371(11):1016-27. doi: 10.1056/NEJMoa1407024. Epub 2014 Sep 1. N Engl J Med. 2014. PMID: 25175921 Free article. Clinical Trial.
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.
Lapostolle F, Van't Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, Silvain J, Lassen JF, Heutz WMJM, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Ten Berg J, Zeymer U, Licour M, Tsatsaris A, Montalescot G; ATLANTIC Investigators. Lapostolle F, et al. Am J Cardiovasc Drugs. 2019 Apr;19(2):173-183. doi: 10.1007/s40256-018-0305-0. Am J Cardiovasc Drugs. 2019. PMID: 30353444 Clinical Trial.
Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
Montalescot G, van 't Hof AW, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Collet JP, Goodman SG, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Licour M, Merkely B, Salhi N, Silvain J, Storey RF, Ten Berg JM, Tsatsaris A, Zeymer U, Vicaut E, Hamm CW; ATLANTIC Investigators. Montalescot G, et al. JACC Cardiovasc Interv. 2016 Apr 11;9(7):646-56. doi: 10.1016/j.jcin.2015.12.024. Epub 2016 Mar 5. JACC Cardiovasc Interv. 2016. PMID: 26952907 Free article. Clinical Trial.
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Bhatt DL, et al. Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1. Lancet. 2019. PMID: 31484629 Free article. Clinical Trial.
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVI National Registry 2010-2011.
Sabaté M, Cánovas S, García E, Hernández Antolín R, Maroto L, Hernández JM, Alonso Briales JH, Muñoz García AJ, Gutiérrez-Ibañes E, Rodríguez-Roda J; collaborators of the TAVI National Group. Sabaté M, et al. Rev Esp Cardiol (Engl Ed). 2013 Dec;66(12):949-58. doi: 10.1016/j.rec.2013.07.003. Epub 2013 Oct 4. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24774108
Comments on the ESC/ESH guidelines for the management of arterial hypertension 2013. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
Grupo de Trabajo de la SEC sobre la guía de hipertensión arterial ESC/ESH 2013, revisores expertos de la guía de hipertensión arterial ESC/ESH 2013 y Comité de Guías de Práctica Clínica de la SEC. Grupo de Trabajo de la SEC sobre la guía de hipertensión arterial ESC/ESH 2013, revisores expertos de la guía de hipertensión arterial ESC/ESH 2013 y Comité de Guías de Práctica Clínica de la SEC. Rev Esp Cardiol (Engl Ed). 2013 Nov;66(11):842-7. doi: 10.1016/j.rec.2013.08.003. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24773990 No abstract available.